ZEB1 and posterior cortical atrophy: The lack of Zeb1 induction during Enza/Ohmline co-treatment in human PCa slices is an encouraging finding, opening new therapeutic perspectives with Ohmline being a promising compound to be developed as the first class of lipid-anticancer agents.